Author/Creator: Kelley, S. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Kelley, S.

11. Mitochondria-targeted doxorubicin: A new therapeutic strategy against drug-resistant osteosarcoma. (December 2016)

Authors:: Buondonno, I.; Gazzano, E.; Sea Rin, J.; Audrito, V.; Kopecka, J.; Fanelli, M.; Salaroglio, I.C.; Costamagna, C.; Roato, I.; Mungo, E.; Hattinger, C.; Deaglio, S.; Kelley, S.; Serra, M.; Riganti, C.
Journal:: European journal of cancer
Issue:: Volume 69(2016)supplement 1
Page Start:: S71
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

12. Repeat administration of triamcinolone acetonide extended-release affords consistent, clinically relevant improvements in pain: results from a phase 3B, single-arm, open-label study. (April 2019)

Authors:: Gomoll, A.; Spitzer, A.; Richmond, J.C.; Kraus, V.B.; Jones, D.G.; Huffman, K.M.; Cinar, A.; Lufkin, J.; Kelley, S.
Journal:: Osteoarthritis and cartilage
Issue:: Volume 27(2019)Supplement 1
Page Start:: S505
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

13. Safety and systemic exposure of triamcinolone acetonide following intra-articular injection of triamcinolone acetonide extended-release or standard triamcinolone in patients with hip osteoarthritis. (April 2019)

Authors:: Kivitz, A.; Mehra, P.; Hanson, P.; Levy, L.; Kwong, L.; Cinar, A.; Lufkin, J.; Kelley, S.
Journal:: Osteoarthritis and cartilage
Issue:: Volume 27(2019)Supplement 1
Page Start:: S504
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

14. Systemic and local effects following intra-articular injection of FX006, an extended release, PLGA microsphere formulation of triamcinolone acetonide: results from two nonclinical toxicity studies in dogs. (April 2017)

Authors:: Williamson, T.L.; Walz, A.; Garlick, D.; Lightfoot-Dunn, R.; Schafer, K.; Kelley, S.; Bodick, N.
Journal:: Osteoarthritis and cartilage
Issue:: Volume 25(2017)Supplement 1
Page Start:: S431
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

15. Triamcinolone acetonide extended-release injectable suspension (TA-ER) is associated with reduced blood glucose elevation vs. standard triamcinolone in type 2 diabetes mellitus patients with knee osteoarthritis: a randomized, blinded, parallel-group study. (April 2018)

Authors:: Conaghan, P.G.; Russell, S.J.; Sala, R.; Habib, G.; Vo, Q.; Manning, R.; Kivitz, A.; Davis, Y.; Lufkin, J.; Johnson, J.R.; Kelley, S.
Journal:: Osteoarthritis and cartilage
Issue:: Volume 26(2018)Supplement 1
Page Start:: S230
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

16. Triamcinolone acetonide extended-release injectable suspension (TA-ER) provides clinically relevant improvements in pain and function of knee osteoarthritis: a pooled analysis of 3 randomized clinical trials employing composite assessments. (April 2018)

Authors:: Katz, N.P.; Conaghan, P.G.; Kraus, V.B.; Lufkin, J.; Johnson, J.R.; Kelley, S.
Journal:: Osteoarthritis and cartilage
Issue:: Volume 26(2018)Supplement 1
Page Start:: S232
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗